Showing results (361-370 of 398) with videos related to

Sort By:
Pageof 40
JAMA|January 11, 2022
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical TrialNeil A Goldenberg, John M Kittelson, Thomas C Abshire, et al.
Annals of Internal Medicine|June 7, 2006
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trialClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
Thrombosis and Haemostasis|February 1, 1996
Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgeryM T Nurmohamed, A M van Riel, C M Henkens, et al.
The Lancet. Haematology|July 2, 2022
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trialFrank Cools, Saverio Virdone, Jitendra Sawhney, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillationKeith A A Fox, Saverio Virdone, Karen S Pieper, et al.
Plos One|January 26, 2018
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillationJean-Pierre Bassand, Gabriele Accetta, Wael Al Mahmeed, et al.
Chest|March 26, 2011
Predictive and associative models to identify hospitalized medical patients at risk for VTEAlex C Spyropoulos, Frederick A Anderson, Gordon FitzGerald, et al.
JAMA Network Open|February 27, 2020
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial FibrillationKeith A A Fox, Priscilla Velentgas, A John Camm, et al.
European Heart Journal|July 1, 2016
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AFJean-Pierre Bassand, Gabriele Accetta, Alan John Camm, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF RegistryFrank Cools, Dana Johnson, Alan J Camm, et al.
Pageof 40